Bloomage BioTechnology Corporation Limited 688363.SS Stock
Bloomage BioTechnology Corporation Limited Price Chart
Bloomage BioTechnology Corporation Limited 688363.SS Financial and Trading Overview
Contents
- Bloomage BioTechnology Corporation Limited Price Chart
- Bloomage BioTechnology Corporation Limited 688363.SS Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Bloomage BioTechnology Corporation Limited
- Q&A For Bloomage BioTechnology Corporation Limited Stock
Bloomage BioTechnology Corporation Limited stock price | 53.85 CNY |
Previous Close | 94.18 CNY |
Open | 95.36 CNY |
Bid | 93.37 CNY x N/A |
Ask | 93.4 CNY x N/A |
Day's Range | 92.97 - 95.36 CNY |
52 Week Range | 84.99 - 164.66 CNY |
Volume | 2.21M CNY |
Avg. Volume | 3.29M CNY |
Market Cap | 44.97B CNY |
Beta (5Y Monthly) | 0.702496 |
PE Ratio (TTM) | 43.63084 |
EPS (TTM) | 1.67 CNY |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | May 16, 2022 |
1y Target Est | 129.15 CNY |
688363.SS Valuation Measures
Enterprise Value | 43.08B CNY |
Trailing P/E | 43.63084 |
Forward P/E | 27.542772 |
PEG Ratio (5 yr expected) | 1.05 |
Price/Sales (ttm) | 7.0168247 |
Price/Book (mrq) | 6.531198 |
Enterprise Value/Revenue | 6.721 |
Enterprise Value/EBITDA | 38.31 |
Trading Information
Bloomage BioTechnology Corporation Limited Stock Price History
Beta (5Y Monthly) | 0.702496 |
52-Week Change | -36.48% |
S&P500 52-Week Change | 20.43% |
52 Week High | 164.66 CNY |
52 Week Low | 84.99 CNY |
50-Day Moving Average | 98.05 CNY |
200-Day Moving Average | 117.6 CNY |
688363.SS Share Statistics
Avg. Volume (3 month) | 3.29M CNY |
Avg. Daily Volume (10-Days) | 3.38M CNY |
Shares Outstanding | 481.68M |
Float | 147.7M |
Short Ratio | N/A |
% Held by Insiders | 60.63% |
% Held by Institutions | 14.65% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.61 |
Trailing Annual Dividend Yield | 0.64% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.24379998 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 15.15% |
Operating Margin (ttm) | 14.86% |
Gross Margin | 76.01% |
EBITDA Margin | 17.54% |
Management Effectiveness
Return on Assets (ttm) | 7.50% |
Return on Equity (ttm) | 14.89% |
Income Statement
Revenue (ttm) | 6.41B CNY |
Revenue Per Share (ttm) | 13.32 CNY |
Quarterly Revenue Growth (yoy) | 4.00% |
Gross Profit (ttm) | 6.36B CNY |
EBITDA | 1.12B CNY |
Net Income Avi to Common (ttm) | 971.65M CNY |
Diluted EPS (ttm) | 2.14 |
Quarterly Earnings Growth (yoy) | 0.40% |
Balance Sheet
Total Cash (mrq) | 1.59B CNY |
Total Cash Per Share (mrq) | 3.3 CNY |
Total Debt (mrq) | 341.08M CNY |
Total Debt/Equity (mrq) | 4.92 CNY |
Current Ratio (mrq) | 2.765 |
Book Value Per Share (mrq) | 14.296 |
Cash Flow Statement
Operating Cash Flow (ttm) | 654.02M CNY |
Levered Free Cash Flow (ttm) | -356094144 CNY |
Profile of Bloomage BioTechnology Corporation Limited
Country | China |
State | N/A |
City | Jinan |
Address | Tech Development Zone |
ZIP | 250101 |
Phone | 86 531 8268 5998 |
Website | https://www.bloomagebioactive.com |
Industry | Specialty Chemicals |
Sector(s) | Basic Materials |
Full Time Employees | 4278 |
Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under the Hybloom, miniHA, microHA, Hyacross, Hyacolor, and cationHA. The company also provides food-grade sodium hyaluronate for use in food/healthy food/dietary supplements under the HAPLEX name, as well as food-grade gamma aminobutyric acid under the Gabarelax name; hyaluronic acid for oral care under the Biomoist name; and animal care products under the HYAPET names. Bloomage BioTechnology Corporation Limited was founded in 2000 and is headquartered in Jinan, the People's Republic of China.
Q&A For Bloomage BioTechnology Corporation Limited Stock
What is a current 688363.SS stock price?
Bloomage BioTechnology Corporation Limited 688363.SS stock price today per share is 53.85 CNY.
How to purchase Bloomage BioTechnology Corporation Limited stock?
You can buy 688363.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bloomage BioTechnology Corporation Limited?
The stock symbol or ticker of Bloomage BioTechnology Corporation Limited is 688363.SS.
Which industry does the Bloomage BioTechnology Corporation Limited company belong to?
The Bloomage BioTechnology Corporation Limited industry is Specialty Chemicals.
How many shares does Bloomage BioTechnology Corporation Limited have in circulation?
The max supply of Bloomage BioTechnology Corporation Limited shares is 481.68M.
What is Bloomage BioTechnology Corporation Limited Price to Earnings Ratio (PE Ratio)?
Bloomage BioTechnology Corporation Limited PE Ratio is 32.24551000 now.
What was Bloomage BioTechnology Corporation Limited earnings per share over the trailing 12 months (TTM)?
Bloomage BioTechnology Corporation Limited EPS is 1.67 CNY over the trailing 12 months.
Which sector does the Bloomage BioTechnology Corporation Limited company belong to?
The Bloomage BioTechnology Corporation Limited sector is Basic Materials.